Research ExplorerScientific StaffFrancis Ayuketang Ayuk Publications

PD Dr. med. ID: 49552

Francis Ayuketang Ayuk

graph of relations
Affiliations
151 - 200 out of 210Page size: 50

Publications

  1. 2012

  2. Risk models predicting survival after reduced-intensity transplantation for myelofibrosis.

    Alchalby, H., Yunus, D-R., Zabelina, T., Kobbe, G., Holler, E., Bornhäuser, M., Schwerdtfeger, R., Bethge, W., Kvasnicka, H. M., Büsche, G., Ayuketang Ayuk, F., Bacher, U., Zander, A. R. & Kröger, N., 2012, In: BRIT J HAEMATOL. 157, 1, p. 75-85 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. 2011

  4. Purification of CD4+ T cells for adoptive immunotherapy after allogeneic hematopoietic stem cell transplantation

    Klyuchnikov, E., Sputtek, A., Slesarchuk, O., Lioznov, M., Stübig, T., Bacher, U., Amtsfeld, G., Merle, E., Reckhaus, M-L., Fehse, B., Wolschke, C., Adjalle, R., Ayuketang Ayuk, F., Zander, A. R. & Kröger, N., 01.03.2011, In: BIOL BLOOD MARROW TR. 17, 3, p. 374-383 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. Caspofungin plus posaconazole as salvage therapy of invasive fungal infections in immunocompromised patients.

    Lellek, H., Waldenmaier, D., Dahlke, J., Ayuketang Ayuk, F., Wolschke, C., Kröger, N. & Zander, A. R., 2011, In: MYCOSES. 54, 1, p. 39-44 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  6. Circulating CD34(+) cells as prognostic and follow-up marker in patients with myelofibrosis undergoing allo-SCT.

    Alchalby, H., Lioznov, M., Fritzsche-Friedland, U., Badbaran, A., Zabelina, T., Bacher, U., Stübig, T., Ayuketang Ayuk, F., Zander, A. R. & Kröger, N., 2011, In: BONE MARROW TRANSPL. 47, 1, p. 143-145 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease.

    Wolff, D., Schleuning, M., von Harsdorf, S., Bacher, U., Gerbitz, A., Stadler, M., Ayuketang Ayuk, F., Kiani, A., Schwerdtfeger, R., Vogelsang, G. B., Kobbe, G., Gramatzki, M., Lawitschka, A., Mohty, M., Pavletic, S. Z., Greinix, H. & Holler, E., 2011, In: BIOL BLOOD MARROW TR. 17, 1, p. 1-17 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  8. Donor KIR haplotype B improves progression-free and overall survival after allogeneic hematopoietic stem cell transplantation for multiple myeloma.

    Kröger, N., Zabelina, T., Berger, J., Duske, H., Klyuchnikov, E., Binder, T., Stübig, T., Hildebrandt, Y., Atanackovic, D., Alchalby, H., Ayuketang Ayuk, F., Zander, A. R., Bacher, U. & Eiermann, T., 2011, In: LEUKEMIA. 25, 10, p. 1657-1661 10.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  9. The Role of Allogeneic Stem Cell Transplantation in Relapsed/Refractory Hodgkin's Lymphoma Patients.

    Klyuchnikov, E., Bacher, U., Kröger, N., Kazantsev, I., Zabelina, T., Ayuketang Ayuk, F. & Zander, A. R., 2011, In: ANN HEMATOL. 2011, p. 974658

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  10. 2010

  11. Minimal residual disease diagnostics in patients with acute myeloid leukemia in the post-transplant period: comparison of peripheral blood and bone marrow analysis.

    Stahl, T., Badbaran, A., Kröger, N., Klyuchnikov, E., Zabelina, T., Zeschke, S., Schafhausen, P., Schultz, W., Asenova, S., Smirnova, A., Wolschke, C., Ayuketang Ayuk, F., Zander, A. R., Fehse, B. & Bacher, U., 01.10.2010, In: LEUKEMIA LYMPHOMA. 51, 10, p. 1837-1843 7 p., 10.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  12. Influence of mannose-binding lectin genotypes and serostatus in allo-SCT: analysis of 131 recipients and donors.

    Neth, O. W., Bacher, U., Das, P., Zabelina, T., Kabisch, H., Kroeger, N., Ayuketang, F. A., Lioznov, M., Waschke, O., Fehse, B., Thiébaut, R., Haston, R. M., Klein, N. & Zander, A. R., 01.01.2010, In: BONE MARROW TRANSPL. 45, 1, p. 13-9 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. Allogenic hematopoietic stem-cell transplantation with reduced-intensity conditioning in patients with refractory and recurrent multiple myeloma: long-term follow-up.

    Shimoni, A., Hardan, I., Ayuketang Ayuk, F., Schilling, G., Atanackovic, D., Zeller, W., Yerushalmi, R., Zander, A. R., Kröger, N. & Nagler, A., 2010, In: CANCER-AM CANCER SOC. 116, 15, p. 3621-3630 15.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  14. Chimerism studies with quantitative real-time PCR in stem cell recipients with acute myeloid leukemia.

    Wiedemann, B., Klyuchnikov, E., Kröger, N., Zabelina, T., Stahl, T., Zeschke, S., Badbaran, A., Ayuketang Ayuk, F., Alchalby, H., Wolschke, C., Bokemeyer, C., Fehse, B., Zander, A. R. & Bacher, U., 2010, In: EXP HEMATOL. 38, 12, p. 1261-1271 12.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  15. Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): first-line and topical treatment of chronic GVHD.

    Wolff, D., Gerbitz, A., Ayuketang Ayuk, F., Kiani, A., Hildebrandt, G. C., Vogelsang, G. B., Elad, S., Lawitschka, A., Socie, G., Pavletic, S. Z., Holler, E. & Greinix, H., 2010, In: BIOL BLOOD MARROW TR. 16, 12, p. 1611-1628 12.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  16. Diagnosis of Toxoplasma gondii infection after allogeneic stem cell transplant can be difficult and requires intensive scrutiny.

    Cavattoni, I., Ayuketang Ayuk, F., Zander, A. R., Zabelina, T., Bacher, A., Cayiroglu, E., Knospe, V., Illies, T., Aepfelbacher, M., Richard, G., Kröger, N. & Bacher, U., 2010, In: LEUKEMIA LYMPHOMA. 51, 8, p. 1530-1535 8.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  17. Immunohistochemistry and molecular analyses in myeloid sarcoma of the breast in a patient with relapse of NPM1-mutated and FLT3-mutated AML after allogeneic stem cell transplantation.

    Choschzick, M., Bacher, U., Ayuketang Ayuk, F. & Lebeau, A., 2010, In: J CLIN PATHOL. 63, 6, p. 558-561 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  18. Pilot study of rituximab plus donor-lymphocyte infusion to prevent or treat relapse in B-cell lymphoma after allogeneic stem cell transplantation.

    Cavattoni, I., Zabelina, T., Ayuketang Ayuk, F., Wolschke, C., Bacher, U., Zander, A. R. & Kröger, N., 2010, In: LEUKEMIA LYMPHOMA. 51, 1, p. 146-148 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  19. Post-transplant immune reconstitution after unrelated allogeneic stem cell transplant in patients with acute myeloid leukemia.

    Klyuchnikov, E., Asenova, S., Kern, W., Kilinc, G., Ayuketang Ayuk, F., Wiedemann, B., Lioznov, M., Freiberger, P., Zalyalov, Y., Zander, A. R., Kröger, N. & Bacher, U., 2010, In: LEUKEMIA LYMPHOMA. 51, 8, p. 1450-1463 8.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  20. Second Allogeneic Stem Cell Transplantation in a Patient with Hypoplastic Myelodysplastic Syndrome following a Primary Diagnosis of Aplastic Anaemia.

    Ocheni, S., Oyekunle, A., Kröger, N., Ayuketang Ayuk, F., Klyuchnikov, E., Arps, S., Held, K., Zabelina, T., Adjalle, R., Wolschke, C., Zander, A. R. & Bacher, U., 2010, In: ACTA HAEMATOL-BASEL. 125, 3, p. 175-178 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  21. 2009

  22. Antitumor effects of polyclonal antithymocyte globulins: focus on B-cell malignancies and multiple myeloma.

    Ayuketang Ayuk, F., Zander, A. R. & Kröger, N., 2009, In: ANN HEMATOL. 88, 5, p. 401-404 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  23. Bone marrow mesenchymal stromal cells remain of recipient origin after allogeneic SCT and do not harbor the JAK2V617F mutation in patients with myelofibrosis.

    Bacher, U., Asenova, S., Badbaran, A., Zander, A. R., Alchalby, H., Fehse, B., Kröger, N., Lange, C. & Ayuketang Ayuk, F., 2009, In: CLIN EXP MED.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  24. Characterisation of extramedullary relapse in patients with chronic myeloid leukemia in advanced disease after allogeneic stem cell transplantation.

    Ocheni, S., Iwanski, G., Schafhausen, P., Zander, A. R., Ayuketang Ayuk, F., Klyuchnikov, E., Zabelina, T., Fiedler, W., Schnittger, S., Hochhaus, A., Brümmendorf, T., Kröger, N. & Bacher, U., 2009, In: LEUKEMIA LYMPHOMA. 50, 4, p. 551-558 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  25. Comparison of the cytotoxicity of 4 preparations of anti-T-cell globulins in various hematological malignancies.

    Ayuketang Ayuk, F., Maywald, N., Hannemann, S., Larsen, U., Zander, A. R. & Kröger, N., 2009, In: ANTICANCER RES. 29, 4, p. 1355-1360 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  26. HLA-mismatched unrelated donors as an alternative graft source for allogeneic stem cell transplantation after antithymocyte globulin-containing conditioning regimen.

    Kröger, N., Zabelina, T., Binder, T., Ayuketang Ayuk, F., Bacher, U., Amtsfeld, G., Lellek, H., Schrum, J., Erttmann, R., Eiermann, T. & Zander, A. R., 2009, In: BIOL BLOOD MARROW TR. 15, 4, p. 454-462 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  27. JAK2-V617F-triggered preemptive and salvage adoptive immunotherapy with donor-lymphocyte infusion in patients with myelofibrosis after allogeneic stem cell transplantation.

    Kröger, N., Alchalby, H., Klyuchnikov, E., Badbaran, A., Hildebrandt, Y., Ayuketang Ayuk, F., Bacher, U., Bock, O., Kvasnicka, M., Fehse, B. & Zander, A. R., 2009, In: BLOOD. 113, 8, p. 1866-1868 8.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  28. Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44(+)) and T (HLA-DR(+)) cells.

    Lioznov, M., El-Cheikh, J., Hoffmann, F., Hildebrandt, Y., Ayuketang Ayuk, F., Wolschke, C., Atanackovic, D., Schilling, G., Badbaran, A., Bacher, U., Fehse, B., Zander, A. R., Blaise, D., Mohty, M. & Kröger, N., 2009, In: BONE MARROW TRANSPL.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  29. Pegfilgrastim compared to lenograstim after allogeneic peripheral blood stem-cell transplantation from unrelated donors.

    Ocheni, S., Zabelina, T., Bacher, U., Ayuketang Ayuk, F., Zander, A. R. & Kröger, N., 2009, In: LEUKEMIA LYMPHOMA. 50, 4, p. 612-618 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  30. Post-transplant immunotherapy with donor-lymphocyte infusion and novel agents to upgrade partial into complete and molecular remission in allografted patients with multiple myeloma.

    Kröger, N., Badbaran, A., Lioznov, M., Schwartz, S., Zeschke, S., Hildebrandt, Y., Ayuketang Ayuk, F., Atanackovic, D., Schilling, G., Zabelina, T., Bacher, U., Klyuchnikov, E., Shimoni, A., Nagler, A., Corradini, P., Fehse, B. & Zander, A. R., 2009, In: EXP HEMATOL. 37, 7, p. 791-798 7.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  31. Second allogeneic stem cell transplantation in myeloid malignancies.

    Hartwig, M., Ocheni, S., Asenova, S., Wiedemann, B., Zabelina, T., Ayuketang Ayuk, F., Kabisch, H., Erttmann, R., Kröger, N., Zander, A. R. & Bacher, U., 2009, In: ACTA HAEMATOL-BASEL. 122, 4, p. 185-192 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  32. Second-generation tyrosine kinase inhibitors in the post-transplant period in patients with chronic myeloid leukemia or Philadelphia-positive acute lymphoblastic leukemia.

    Klyuchnikov, E., Schafhausen, P., Kröger, N., Brümmendorf, T., Osanmaz, O., Asenova, S., Zabelina, T., Ocheni, S., Ayuketang Ayuk, F., Zander, A. R. & Bacher, U., 2009, In: ACTA HAEMATOL-BASEL. 122, 1, p. 6-10 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  33. 2008

  34. Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors.

    Ayuketang Ayuk, F., Diyachenko, G., Zabelina, T., Panse, J., Wolschke, C., Eiermann, T., Binder, T., Fehse, B., Erttmann, R., Kabisch, H., Bacher, U., Kröger, N. & Zander, A. R., 2008, In: EXP HEMATOL. 36, 8, p. 1047-1054 8.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  35. Clinical impact of human Jurkat T-cell-line-derived antithymocyte globulin in multiple myeloma patients undergoing allogeneic stem cell transplantation.

    Ayuketang Ayuk, F., Perez-Simon, J. A., Shimoni, A., Sureda, A., Zabelina, T., Schwerdtfeger, R., Martino, R., Sayer, H. G., Alegre, A., Lahuerta, J-J., Atanackovic, D., Wolschke, C., Nagler, A., Zander, A. R., Miguel, S., Kröger, N. & Kröger, N., 2008, In: HAEMATOLOGICA. 93, 9, p. 1343-1350 9.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  36. Comparison of two doses of antithymocyte globulin in patients undergoing matched unrelated donor allogeneic stem cell transplantation.

    Ayuketang Ayuk, F., Diyachenko, G., Zabelina, T., Wolschke, C., Fehse, B., Bacher, U., Erttmann, R., Kröger, N. & Zander, A. R., 2008, In: BIOL BLOOD MARROW TR. 14, 8, p. 913-919 8.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  37. Complement-dependent and complement-independent cytotoxicity of polyclonal antithymocyte globulins in chronic lymphocytic leukemia.

    Ayuketang Ayuk, F., Atassi, N., Schuch, G., Mina, S., Fang, L., Bokemeyer, C., Fehse, B., Zander, A. R. & Kröger, N., 2008, In: LEUKEMIA RES. 32, 8, p. 1200-1206 8.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  38. EBV reactivation and post transplant lymphoproliferative disorders following allogeneic SCT.

    Ocheni, S., Kröger, N., Zabelina, T., Sobottka, I., Ayuketang Ayuk, F., Wolschke, C., Muth, A., Lellek, H., Petersen, L., Erttmann, R., Kabisch, H., Zander, A. R. & Bacher, U., 2008, In: BONE MARROW TRANSPL. 42, 3, p. 181-186 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  39. Impact of genetic abnormalities on survival after allogeneic hematopoietic stem cell transplantation in multiple myeloma.

    Schilling, G., Hansen, T., Shimoni, A., Zabelina, T., Pérez-Simón, J-A., Simon-Perez, J-A., Gutierrez, N. C., Fiedler, W., Liebisch, P., Schwerdtfeger, R., Bornhäuser, M., Otterstetter, S., Murga-Penas, E-M., Dierlamm, J., Ayuketang Ayuk, F., Atanackovic, D., Bacher, U., Bokemeyer, C., Zander, A. R., San Miguel, J., Miguel, J. S., Nagler, A. & Kröger, N., 2008, In: LEUKEMIA. 22, 6, p. 1250-1255 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  40. 2007

  41. Monitoring serum free light chains in patients with multiple myeloma who achieved negative immunofixation after allogeneic stem cell transplantation.

    Mösbauer, U., Ayuketang Ayuk, F., Schieder, H., Lioznov, M., Zander, A. R. & Kröger, N., 2007, In: HAEMATOLOGICA. 92, 2, p. 275-276 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  42. 2006

  43. Allogeneic stem-cell transplantation in patients with refractory acute leukemia: a long-term follow-up.

    Oyekunle, A. A., Kröger, N., Zabelina, T., Ayuketang Ayuk, F., Schieder, H., Renges, H., Fehse, N., Waschke, O., Fehse, B., Kabisch, H. & Zander, A. R., 2006, In: BONE MARROW TRANSPL. 37, 1, p. 45-50 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  44. Bortezomib after dose-reduced allogeneic stem cell transplantation for multiple myeloma to enhance or maintain remission status.

    Kröger, N., Zabelina, T., Ayuketang Ayuk, F., Atanackovic, D., Schieder, H., Renges, H. & Zander, A. R., 2006, In: EXP HEMATOL. 34, 6, p. 770-775 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  45. CD34(+)-selected stem cell boost for delayed or insufficient engraftment after allogeneic stem cell transplantation.

    Oyekunle, A., Koehl, U., Schieder, H., Ayuketang Ayuk, F., Renges, H., Fehse, N., Zabelina, T., Fehse, B., Klingebiel, T., Sputtek, A., Zander, A. R. & Kröger, N., 2006, In: CYTOTHERAPY. 8, 4, p. 375-380 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  46. Comparable results in patients with acute lymphoblastic leukemia after related and unrelated stem cell transplantation.

    Dahlke, J., Kröger, N., Zabelina, T., Ayuketang Ayuk, F., Wolschke, C., Renges, H-H., Krüger, W., Kruell, A., Hinke, A., Erttmann, R., Kabisch, H. & Zander, A. R., 2006, In: BONE MARROW TRANSPL. 37, 2, p. 155-163 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  47. Kinetics of plasma-cell chimerism after allogeneic stem cell transplantation by highly sensitive real-time PCR based on sequence polymorphism and its value to quantify minimal residual disease in patients with multiple myeloma.

    Kröger, N., Zagrivnaja, M., Schwartz, S., Badbaran, A., Zabelina, T., Lioznov, M., Ayuketang Ayuk, F., Zander, A. R. & Fehse, B., 2006, In: EXP HEMATOL. 34, 5, p. 688-694 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  48. Low number of donor activating killer immunoglobulin-like receptors (KIR) genes but not KIR-ligand mismatch prevents relapse and improves disease-free survival in leukemia patients after in vivo T-cell depleted unrelated stem cell transplantation.

    Kröger, N., Binder, T., Zabelina, T., Wolschke, C., Schieder, H., Renges, H., Ayuketang Ayuk, F., Dahlke, J., Eiermann, T. & Zander, A. R., 2006, In: TRANSPLANTATION. 82, 8, p. 1024-1030 8.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  49. Prognostic factors for donor lymphocyte infusions following non-myeloablative allogeneic stem cell transplantation in multiple myeloma.

    van de Donk, N. W. C. J., Kröger, N., Hegenbart, U., Corradini, P., San Miguel, J. F., Goldschmidt, H., Perez-Simon, J. A., Zijlmans, M., Raymakers, R. A., Montefusco, V., Ayuketang Ayuk, F., van Oers, M. H. J., Nagler, A., Verdonck, L. F. & Lokhorst, H. M., 2006, In: BONE MARROW TRANSPL. 37, 12, p. 1135-1141 12.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  50. Reduced-toxicity conditioning with treosulfan, fludarabine and ATG as preparative regimen for allogeneic stem cell transplantation (alloSCT) in elderly patients with secondary acute myeloid leukemia (sAML) or myelodysplastic syndrome (MDS).

    Kröger, N., Shimoni, A., Zabelina, T., Schieder, H., Panse, J., Ayuketang Ayuk, F., Wolschke, C., Renges, H., Dahlke, J., Atanackovic, D., Nagler, A. & Zander, A. R., 2006, In: BONE MARROW TRANSPL. 37, 4, p. 339-344 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  51. Remarkable activity of novel agents bortezomib and thalidomide in patients not responding to donor lymphocyte infusions following nonmyeloablative allogeneic stem cell transplantation in multiple myeloma.

    Donk, V. D., Kröger, N., Kröger, N., Hegenbart, U., Corradini, P., Miguel, S., Jesus, F., Goldschmidt, H., Perez-Simon, J. A., Zijlmans, M., Ayuketang Ayuk, F., Montefusco, V., Ayuk, F. A., Oers, V., Marinus, H. J., Nagler, A., Verdonck, L. F. & Lokhorst, H. M., 2006, In: BLOOD. 107, 8, p. 3415-3416 8.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  52. 2005

  53. Antithymocyte globulin induces complement-dependent cell lysis and caspase-dependent apoptosis in myeloma cells.

    Ayuketang Ayuk, F., Fang, L., Fehse, B., Zander, A. R. & Kröger, N., 2005, In: EXP HEMATOL. 33, 12, p. 1531-1536 12.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  54. Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch after dose-reduced conditioning and unrelated stem cell transplantation in patients with multiple myeloma.

    Kröger, N., Shaw, B., Iacobelli, S., Zabelina, T., Peggs, K., Shimoni, A., Nagler, A., Binder, T., Eiermann, T., Madrigal, A., Schwerdtfeger, R., Kiehl, M., Sayer, H. G., Beyer, J., Bornhäuser, M., Ayuketang Ayuk, F., Zander, A. R. & Marks, D. I., 2005, In: BRIT J HAEMATOL. 129, 5, p. 631-643 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  55. Hematopoietic stem-cell transplantation from unrelated donors in elderly patients (age >55 years) with hematologic malignancies: older age is no longer a contraindication when using reduced intensity conditioning.

    Shimoni, A., Kröger, N-M., Zabelina, T., Ayuketang Ayuk, F., Hardan, I., Yeshurun, M., Shem-Tov, N., Avigdor, A., Ben-Bassat, I., Zander, A. & Nagler, A., 2005, In: LEUKEMIA. 19, 1, p. 7-12 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  56. 2004

  57. Efficacy and toxicity of low-dose escalating donor lymphocyte infusion given after reduced intensity conditioning allograft for multiple myeloma.

    Ayuketang Ayuk, F., Shimoni, A., Nagler, A., Schwerdtfeger, R., Kiehl, M., Sayer, H. G., Zabelina, T., Zander, A. R. & Kröger, N., 2004, In: LEUKEMIA. 18, 3, p. 659-662 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  58. Evidence for increased risk of secondary graft failure after in vivo depletion of suicide gene-modified T lymphocytes transplanted in conjunction with CD34+-enriched blood stem cells.

    Fehse, B., Ayuketang Ayuk, F., Kröger, N., Fang, L., Kühlcke, K., Heinzelmann, M., Zabelina, T., Fauser, A. A. & Zander, A. R., 2004, In: BLOOD. 104, 10, p. 3408-3409 10.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  59. Low-dose thalidomide and donor lymphocyte infusion as adoptive immunotherapy after allogeneic stem cell transplantation in patients with multiple myeloma.

    Kröger, N-M., Shimoni, A., Zagrivnaja, M., Ayuketang Ayuk, F., Lioznov, M., Schieder, H., Renges, H-H., Fehse, B., Zabelina, T., Nagler, A. & Zander, A., 2004, In: BLOOD. 104, 10, p. 3361-3363 10.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Previous 1 2 3 4 5 Next